Craig Martin - Pharm.D., BCPS

Dr. Martin received his Doctor of Pharmacy degree from the University of Kentucky College of Pharmacy in 1999 and completed an Infectious Diseases Specialty Residency at UK in 2002.

Dr. Martin serves as the clinical pharmacist for UK Hospital’s Antimicrobial Management Team. The AMT serves to provide patients of the UK Chandler Medical Center with appropriate, cost-effective antimicrobial therapy through formulary management and patient-specific interventions. The Antimicrobial Management Program has been successful in reducing both resistance rates and expenditures on antimicrobial agents. Dr. Martin serves as a lecturer on infectious diseases and counter-terrorism in the first, second, and third professional year curriculum. He also provides experiential education to fourth professional year students through the antimicrobial management and infectious diseases rotations.

Dr. Martin is a recipient of ASHP’s “Best Practice Award” for 2004 as well as the Society of Infectious Diseases Pharmacists’ “Outstanding Clinical Practice in Infectious Diseases Pharmacotherapy” award for 2005.

Selected Honors

• Induction into Rho Chi Pharmaceutical Honor Society (2006)
• Society of Infectious Diseases Pharmacists "Outstanding Clinical Practice in Infectious Diseases Pharmacotherapy Award." (2005)
• Martin C, Rapp R, Armitstead J, Evans M, Hoven A. American Society of Health System Pharmacists "Best Practice Award for 2004." (2004)

Selected Publications/Presentations

• Dodds-Ashley ES, Lewis R, Lewis J, Martin C, Andes D. Pharmacology of Systemic Antifungal Agents. Clinical Infectious Diseases 2006;43:S28-39.
• Papadapoulos S, Ball AM, Liewer SE, Martin CA, Winstead PS, Murphy BS. Rhabdomyolysis During Therapy with Daptomycin. Clinical Infectious Diseases 2006;42:e108-110.
• Martin C, Ofotokun I, Rapp R, Empey K, Armitstead J, Pomeroy C, Hoven A, Evans M. Results of a Five-Year Project to Control the Use of Antimicrobial Agents at a University Hospital. American Journal of Health-System Pharmacy 2005;62:732-8.
• Rapp RP, Evans ME, Martin C, Ofotokun I, Empey KL, Armitstead JA. Drug Costs and Bacterial Susceptibility After Implementing a Single-Fluoroquinolone Use Policy at a University Hospital. Current Medical Research and Opinion. 2004; 20(4):469-76.
• Martin CA, Roberts S, Greenberg RN. Voriconazole Treatment of Disseminated Paecilomyces Infection in a Patient With Acquired Immunodeficiency Syndrome. Clinical Infectious Diseases. 2002; 35(7): e78-81.